Douglas J. M. Allen

Person

New London, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Diphosphate salt of a 4″—substituted-9-deoxo-9 A—AZA—homoerythromyc...
- Patent number 7,297,682
- Issue date Nov 20, 2007
- Pfizer Inc.
- Robert J. Rafka
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diphosphate salt of A 4″-substituted-9-deoxo-9A-AZA-9A-homoerythrom...
- Patent number 6,861,412
- Issue date Mar 1, 2005
- Pfizer, Inc.
- Robert J. Rafka
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine...
- Patent number 6,706,721
- Issue date Mar 16, 2004
- OSI Pharmaceuticals, Inc.
- Douglas John Meldrum Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-(indole-2-carbonyl)-b-alaninamide crystal forms
- Patent number 6,683,106
- Issue date Jan 27, 2004
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of macrolide antibiotic
- Patent number 6,583,274
- Issue date Jun 24, 2003
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- hom...
- Patent number 6,465,437
- Issue date Oct 15, 2002
- Pfizer Inc.
- Robert J. Rafka
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-...
- Patent number 6,436,987
- Issue date Aug 20, 2002
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azithromycin dihydrate
- Patent number 6,268,489
- Issue date Jul 31, 2001
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydr...
- Patent number 6,262,067
- Issue date Jul 17, 2001
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of synthesis of pyrrole amides
- Patent number 6,262,272
- Issue date Jul 17, 2001
- Pfizer Inc.
- John Anthony Ragan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Trovafloxacin oral suspensions
- Patent number 6,239,141
- Issue date May 29, 2001
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing 5-lipoxygenase inhibitors
- Patent number 6,194,585
- Issue date Feb 27, 2001
- Pfizer Inc.
- Charles Kwon-Fung Chiu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin
- Patent number 6,080,756
- Issue date Jun 27, 2000
- Pfizer Inc.
- Timothy Norris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dimesylate salts of neuropeptide Y ligands
- Patent number 5,914,329
- Issue date Jun 22, 1999
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spirostanyl glycosidal crystals
- Patent number 5,804,562
- Issue date Sep 8, 1998
- Pfizer Inc.
- Douglas John Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spirostanyl glycosidal crystalline monohydrate
- Patent number 5,760,009
- Issue date Jun 2, 1998
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-eth...
- Patent number 5,312,925
- Issue date May 17, 1994
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sertraline polymorph
- Patent number 5,248,699
- Issue date Sep 28, 1993
- Pfizer Inc.
- Robert J. Sysko
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxin...
- Patent number 5,036,099
- Issue date Jul 30, 1991
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl) thia...
- Patent number 4,997,949
- Issue date Mar 5, 1991
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
POLYMORPHS OF NICOTINIC INTERMEDIATES
- Publication number 20100062046
- Publication date Mar 11, 2010
- Douglas J.M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diphosphate salt of a "4" - substituted-9-deoxo-9 A - AZA - homoery...
- Publication number 20040209826
- Publication date Oct 21, 2004
- Robert J. Rafka
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-(indole-2-carbonyl)-b-alaninamide crystal forms
- Publication number 20040152758
- Publication date Aug 5, 2004
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N- (3-ethynylphenyl) -6, 7-bis (2-methoxyethoxy) -4-quinazolinamine...
- Publication number 20040102463
- Publication date May 27, 2004
- OSI Pharmaceuticals, Inc.
- Douglas John Meldrum Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-(indole-2-carbonyl)-b-alaninamide crystal forms
- Publication number 20030195243
- Publication date Oct 16, 2003
- Pfizer Inc.
- Douglas J. M. Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diphosphate salt of a 4" -substituted-9-deoxo-9A-AZA-9A-homoerythro...
- Publication number 20030092642
- Publication date May 15, 2003
- Robert J. Rafka
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(p...
- Publication number 20020035144
- Publication date Mar 21, 2002
- Douglas J.M. Allen
- C07 - ORGANIC CHEMISTRY

Douglas J. M. Allen

Person

Patents Grantslast 30 patents

Diphosphate salt of a 4″—substituted-9-deoxo-9 A—AZA—homoerythromyc...

Diphosphate salt of A 4″-substituted-9-deoxo-9A-AZA-9A-homoerythrom...

N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine...

N-(indole-2-carbonyl)-b-alaninamide crystal forms

Crystalline forms of macrolide antibiotic

Diphosphate salt of a 4&#x02033;-substituted-9-deoxo-9A-AZA-9A- hom...

Crystalline forms of (3S-trans)-2-&#x0005B;3,4-dihydro-4-hydroxy-3-...

Azithromycin dihydrate

Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydr...

Method of synthesis of pyrrole amides

Trovafloxacin oral suspensions

Process for preparing 5-lipoxygenase inhibitors

Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin

Dimesylate salts of neuropeptide Y ligands

Spirostanyl glycosidal crystals

Spirostanyl glycosidal crystalline monohydrate

Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-eth...

Sertraline polymorph

Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxin...

Crystalline 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl) thia...

Patents Applicationslast 30 patents

POLYMORPHS OF NICOTINIC INTERMEDIATES

Diphosphate salt of a "4" - substituted-9-deoxo-9 A - AZA - homoery...

N-(indole-2-carbonyl)-b-alaninamide crystal forms

N- (3-ethynylphenyl) -6, 7-bis (2-methoxyethoxy) -4-quinazolinamine...

N-(indole-2-carbonyl)-b-alaninamide crystal forms

Diphosphate salt of a 4" -substituted-9-deoxo-9A-AZA-9A-homoerythro...

Novel crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(p...

Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- hom...

Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-...